Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

36.86B

Market cap36.86B

Price-Earnings ratio

13.65

Price-Earnings ratio13.65

Dividend yield

2.55%

Dividend yield2.55%

Average volume

4.14M

Average volume4.14M

High today

$89.29

High today$89.29

Low today

$83.80

Low today$83.80

Open price

$85.52

Open price$85.52

Volume

9.18M

Volume9.18M

52 Week high

$132.49

52 Week high$132.49

52 Week low

$68.77

52 Week low$68.77

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $87.06. The company's market cap stands at 36.86B, with a P/E ratio of 13.65 and a dividend yield of 2.55%.

During the trading session on 2026-11-04, Zoetis(ZTS) shares reached a daily high of $89.29 and a low of $83.80. At a current price of $87.06, the stock is +3.9% higher than the low and still -2.5% under the high.

Trading volume for Zoetis(ZTS) stock has reached 9.18M, versus its average volume of 4.14M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $132.49 and a low of $68.77.

ZTS News

Simply Wall St 2h

Zoetis Stock Looks Like A Bargain On Earnings

has enjoyed a sharp rebound in recent weeks after a long slide. This puts a fresh spotlight on whether the current share price lines up with what its earnings c...

Simply Wall St 2d

Zoetis Wins FDA Approval For Convenia RTU, Is It Still Below Fair Value?

Advertisement Why the new Convenia approval matters for Zoetis Zoetis (ZTS) just received FDA approval for Convenia RTU for Dogs, a single dose injectable ant...

Simply Wall St 3d

FDA Dog Antibiotic Approval Could Be A Game Changer For Zoetis

Zoetis reported that the FDA approved Convenia RTU for Dogs, a more concentrated cefovecin injection that delivers up to 14 days of treatment for susceptible ba...

Analyst ratings

72%

of 18 ratings

Buy

27.8%

Hold

72.2%

Sell

More ZTS News

Zacks 6d

Zoetis Ascends While Market Falls: Some Facts to Note

Zoetis (ZTS Quick QuoteZTS - Free Report) closed the most recent trading day at $78.80, moving +1.29% from the previous trading session. This change outpa...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.